3 employees
Realm Tx is a clinical stage biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology
2006
$26M
from 4 investors over 4 rounds
Realm Therapeutics, Inc. raised $26M on September 22, 2017
Investors: OrbiMed Advisors, Abingworth, Polar Capital Partners and RA Capital Management, L.P.